ATH doesn't own the patents for antibiotics PBT2, but they should be the owner of the best synthetic routes and GMP facilities. They also have all the safety profiles and relevant clinical data of PBT2. ATH still has a chance to be a partner and share the profits from commercializing PBT2 as an antibiotics. Hope this comes to true... dream it possible
- Forums
- ASX - By Stock
- Ann: Appendix 4E & Annual Report 2019
ATH doesn't own the patents for antibiotics PBT2, but they...
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ATH (ASX) to my watchlist
|
|||||
Last
0.5¢ |
Change
0.001(11.1%) |
Mkt cap ! $26.22M |
Open | High | Low | Value | Volume |
0.5¢ | 0.5¢ | 0.5¢ | $4.263K | 916.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
58 | 69165915 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 38212524 | 21 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
54 | 67315915 | 0.004 |
51 | 47745901 | 0.003 |
17 | 41239402 | 0.002 |
14 | 93470101 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 28202414 | 18 |
0.006 | 34904757 | 14 |
0.007 | 16220649 | 14 |
0.008 | 14174718 | 13 |
0.009 | 6000000 | 5 |
Last trade - 15.11pm 05/07/2024 (20 minute delay) ? |
Featured News
ATH (ASX) Chart |